Pulmonx Corp
(LUNG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -20,703 | -18,479 | N/A | N/A |
| Depreciation Amortization | 332 | 306 | N/A | N/A |
| Accounts receivable | -2,524 | -262 | N/A | N/A |
| Accounts payable and accrued liabilities | 524 | -648 | N/A | N/A |
| Other Working Capital | -2,401 | -1,523 | N/A | N/A |
| Other Operating Activity | 4,007 | 2,212 | 0 | 0 |
| Operating Cash Flow | $-20,765 | $-18,394 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -13,513 | 500 | N/A | N/A |
| PPE Investments | -720 | -300 | N/A | N/A |
| Investing Cash Flow | $-14,233 | $200 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 6,000 | 12,000 | N/A | N/A |
| Common Stock Issued | 528 | 114 | N/A | N/A |
| Common Stock Repurchased | -12 | N/A | N/A | N/A |
| Other Financing Activity | 39,103 | 0 | 0 | 0 |
| Financing Cash Flow | $45,619 | $12,114 | $N/A | $N/A |
| Exchange Rate Effect | 22 | 154 | N/A | N/A |
| Beginning Cash Position | 4,124 | 10,050 | N/A | N/A |
| End Cash Position | 14,767 | 4,124 | N/A | N/A |
| Net Cash Flow | $10,643 | $-5,926 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -20,765 | -18,394 | N/A | N/A |
| Capital Expenditure | -720 | -316 | N/A | N/A |
| Free Cash Flow | -21,485 | -18,710 | 0 | 0 |